FDA Adverse Event Injury Summary report: N

MISIGHT 1 DAY (OMAFILCON A)

MDR report key: 18846316 · Received March 6, 2024

Report

Report Number
3003981983-2024-00001
Event Type
Injury
Date Received
March 6, 2024
Date of Event
February 1, 2024
Report Date
March 6, 2024
Manufacturer
COOPERVISION MANUFACTURING LTD
Product Code
QIT
PMA / PMN Number
P180035
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO PRODUCT HAS BEEN MADE AVAILABLE FOR MANUFACTURER ANALYSIS AND NO LOT NUMBER PROVIDED FOR MANUFACTURER INVESTIGATION. THE RELATIONSHIP BETWEEN THE COOPERVISION AND THE EVENT COULD NOT BE CONFIRMED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED AS APPROPRIATE.

Description of Event or Problem · 0

THIS INCIDENT WAS REPORTED BY THE END USER'S LOCATION OF PURCHASE TO THE MANUFACTURER'S LOCAL CUSTOMER SERVICE OFFICE. INFORMATION PROVIDED INDICATES THAT THE PATIENT WAS SEEN FOR INITIAL FITTING AND FOLLOW-UP IN (B)(6) 2023. ON 28 DECEMBER 2023, AT FITTING FOLLOW-UP, AND REPORTED SYMPTOMS OF PHOTOPHOBIA. IT IS REPORTED THAT THE OCULAR SURFACE WAS HEALTHY BUT THE PATIENT WAS PRESCRIBED UNSPECIFIED ANTI-INFLAMMATORY MEDICINE AND ADVISED TO STOP WEARING THE CONTACT LENS. THE PATIENT WAS SEEN FOR MULTIPLE FOLLOW-UP VISITS WHERE CONTINUED SYMPTOMS WERE REPORTED AND CONTINUATION OF MEDICATION ADVISED. ON 1 FEBRUARY 2024, WHEN SYMPTOMS WERE STILL NOT IMPROVING, THE PATIENT WAS TRANSFERRED TO (B)(6) HOSPITAL, AND REPORTEDLY WAS DIAGNOSED WITH ACANTHAMOEBA KERATITIS AND UNDERWENT CORNEAL TRANSPLANT SURGERY. AS OF THE DATE OF THIS REPORT, TREATMENT IS ONGOING. GOOD FAITH EFFORTS HAVE BEEN MADE TO OBTAIN FURTHER INFORMATION WITHOUT SUCCESS. AS OF THE DATE OF THIS REPORT, ADDITIONAL INFORMATION IS UNKNOWN. THIS EVENT IS BEING REPORTED IN AN ABUNDANCE OF CAUTION DUE TO DIAGNOSIS OF ACANTHAMOEBA KERATITIS DIAGNOSIS WITH SURGICAL INTERVENTION, HOSPITALIZATION AND UNKNOWN PATIENT OUTCOME. SHOULD FURTHER INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED AS APPROPRIATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1565463 MISIGHT 1 DAY (OMAFILCON A) MISIGHT 1 DAY (OMAFILCON A) QIT COOPERVISION MANUFACTURING LTD UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 10 YR Female Other| H| R